Regeneron Pharmaceuticals, Inc. REGN

788.04 (7.98) (1.00%) as of 25 Sep
Market cap
$81.3B
P/E
18.8×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
P/E ratio
17.90 17.42 24.43 17.78 8.26 14.75 19.38 16.50 33.92 45.15
P/S ratio
5.63 5.41 7.36 6.34 4.15 6.12 6.25 7.83 6.93 8.18
P/FCF ratio
21.44 21.60 26.33 22.71 10.22 25.95 20.50 22.24 39.31 40.82
P/Operating CF
68.97 60.87 88.61 44.86 28.14 42.23 52.07 55.30 71.74 101.83
P/B ratio
2.58 2.62 3.72 3.40 3.56 4.71 3.70 4.60 6.62 8.94
Price to Tangible BV
2.69 2.73 3.87 3.55 3.56 4.71 3.70 4.60 6.62 8.94
EV/Sales
5.27 5.02 6.80 5.98 3.97 6.19 5.87 7.42 6.81 8.04
EV/EBITDA
18.33 15.93 19.95 14.34 6.91 13.79 15.91 14.24 17.96 27.22
EV/Operating CF
15.18 16.12 19.40 14.53 9.00 20.09 15.84 17.40 30.57 26.29
EV/FCF
20.07 20.03 24.31 21.44 9.76 26.25 19.25 21.08 38.63 40.11
Quick Ratio
3.28 3.86 4.82 4.16 2.98 2.86 2.86 3.50 2.98 2.13
Current Ratio
4.13 4.73 5.69 5.06 3.56 3.63 3.67 4.47 3.82 2.56
Net Debt/EBITDA
(1.43) (1.41) (1.82) (0.99) (0.40) (0.23) (1.03) (0.78) (0.32) (0.48)
Debt/Assets
6.67% 7.16% 8.17% 9.25% 7.78% 15.71% 4.82% 6.04% 8.03% 5.04%
Debt/Equity
0.09 0.09 0.10 0.12 0.11 0.24 0.06 0.08 0.11 0.08
Asset Turnover
0.37 0.40 0.42 0.45 0.75 0.53 0.49 0.50 0.75 0.77
Operating CF/Net income
1.11 1.00 1.16 1.16 0.88 0.75 1.15 0.90 1.09 1.66
Capex/Depreciation
(2.23) (1.78) (2.20) (4.74) (1.93) (2.61) (2.04) (2.58) (1.87) (4.89)
Interest Coverage
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
ROE
14.87% 15.95% 16.26% 20.94% 54.21% 31.77% 21.32% 32.81% 22.63% 22.10%
ROA
11.50% 12.46% 12.69% 15.88% 37.91% 21.98% 15.94% 23.85% 15.23% 14.23%
ROIC
8.82% 10.82% 14.19% 16.81% 37.14% 22.06% 16.08% 23.80% 23.90% 22.11%
Return on Tangible Assets
24.00% 22.84% 19.57% 26.28% 59.53% 34.10% 24.94% 32.25% 21.56% 22.26%
Average Days of Receivables
146.10 159.65 157.70 159.78 137.09 176.75 155.05 159.12 122.72 121.03
Research and Development Expense of Revenue
40.79% 36.14% 33.84% 29.51% 17.80% 31.15% 37.36% 28.54% 35.34% 42.22%
Selling, General and Administrative Expense of Revenue
18.82% 20.80% 20.06% 17.38% 11.35% 15.84% 20.46% 21.91% 22.49% 24.23%
Intangible Assets out of Total Assets
0.03 0.03 0.03 0.03 0.00 0.00 0.00 0.00 0.00 0.00
Share Based Compensation of Revenue
6.93% 6.92% 6.75% 5.96% 3.74% 5.08% 7.08% 8.31% 8.64% 11.52%
Graham Net Nets
0.11 0.13 0.13 0.12 0.11 0.07 0.10 0.09 0.04 0.02
Graham Number
538.44 500.23 450.47 439.24 552.66 274.82 210.38 203.33 121.12 89.67
Earnings Yield
5.59% 5.74% 4.09% 5.62% 12.11% 6.78% 5.16% 6.06% 2.95% 2.21%
Free Cash Flow Yield
4.66% 4.63% 3.80% 4.40% 9.78% 3.85% 4.88% 4.50% 2.54% 2.45%
Revenue per Share
137.12 131.62 122.94 113.66 152.05 78.97 60.05 47.69 55.24 46.42
Operating CF per Share
47.60 40.97 43.06 46.82 66.99 24.33 22.25 20.34 12.30 14.19
Capex per Share
(11.60) (7.98) (8.68) (15.10) (5.22) (5.71) (3.93) (3.55) (2.56) (4.89)
Free Cash Flow per Share
36.00 32.98 34.37 31.73 61.77 18.62 18.32 16.79 9.73 9.30
Cash per Share
82.27 83.53 101.64 72.29 53.88 33.34 29.44 26.04 13.26 9.92
Shareholders Equity per Share
298.82 272.04 243.42 211.62 177.57 102.47 101.55 81.16 57.80 42.50
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
298.82 272.04 243.42 211.62 177.57 102.47 101.55 81.16 57.80 42.50
Free Cash Flow
3,765.20 3,559.00 3,667.60 3,398.00 6,529.40 2,003.50 2,000.40 1,812.00 1,034.50 974.00
Working Capital
13,653.50 14,716.60 16,055.80 12,742.80 10,082.40 7,081.70 5,592.50 5,004.80 3,199.50 1,938.69
Capital Expenditures
(1,213.70) (861.50) (926.40) (1,616.90) (551.90) (614.60) (429.60) (383.10) (272.60) (511.90)
Net Current Asset Value
8,720.10 10,255.10 12,372.10 9,333.60 7,348.90 3,641.10 3,973.60 3,470.40 1,714.80 655.97
EV/EBIT
21.12 17.86 22.03 15.37 7.13 14.70 17.42 15.07 19.22 29.36
Capex to Sales
0.08 0.06 0.07 0.13 0.03 0.07 0.07 0.07 0.05 0.11
Net Profit Margin
31.41% 31.07% 30.14% 35.64% 50.25% 41.35% 32.26% 47.50% 20.41% 18.42%
Price to Operating Income
22.57 19.26 23.86 16.28 7.46 14.53 18.55 15.90 19.56 29.87
Other line items
Depreciation/Fixed assets
0.11 0.11 0.10 0.09 0.08 0.07 0.07 0.06 0.06 0.05
Cash ROIC
(0.33%) (0.44%) 1.13% 3.78% 13.61% (3.49%) (3.07%) (3.10%) (12.73%) (10.23%)
Accounts Receivable Turnover
2.40 2.39 2.39 2.14 3.17 2.46 2.61 2.44 3.28 3.16
Accounts Payable Turnover
2.43 2.82 3.04 2.71 4.69 2.51 2.40 2.11 0.75 0.39
Inventory Turnover
0.67 0.70 0.73 0.72 1.26 0.67 0.60 0.44 0.71 0.94
Average Days of Payables
163.15 146.24 121.93 137.82 84.46 154.98 199.46 190.76 163.80 1,070.64
Days of Inventory on Hand
556.14 571.87 518.71 561.84 292.19 624.66 675.28 1,006.44 667.40 486.37
Average Receivables
5,976.50 5,939.60 5,498.00 5,682.60 5,075.60 3,450.15 2,514.40 2,108.75 1,792.96 1,539.71
Average Payables
864.25 698.05 597.90 576.60 519.75 446.80 318.15 198.20 528.65 761.60
Average Inventory
3,144.05 2,833.90 2,491.20 2,176.60 1,933.95 1,666.05 1,283.35 938.65 562.73 318.97
Average Assets
39,159.05 35,419.80 31,147.35 27,324.65 21,299.05 15,984.25 13,269.85 10,249.40 7,868.88 6,291.30
Average Common Equity
30,305.25 27,663.35 24,318.55 20,716.40 14,897.05 11,057.50 9,923.50 7,450.70 5,296.67 4,052.04

Fold the line items

Columns are period end dates